US Dollar vs Yen

ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。

登録

ホーム
投資
株式
アメリカ
NYSE
Merck and Co Inc (MRK)
Merck and Co Inc (MRK) ニュース

MRK

Merck (MRK)

Merck and Co Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NYSE:MRK

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/08	19 : 45	Business Wire	Merck to Participate in the Bank of America Securities 2024 Healthcare Conference	NYSE:MRK	Merck and Co Inc
2024/05/07	05 : 29	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NYSE:MRK	Merck and Co Inc
2024/05/07	05 : 10	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:MRK	Merck and Co Inc
2024/05/07	05 : 08	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:MRK	Merck and Co Inc
2024/05/07	05 : 06	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:MRK	Merck and Co Inc
2024/05/07	05 : 01	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:MRK	Merck and Co Inc
2024/05/01	20 : 15	Business Wire	Merck Announces Phase 3 KEYNOTE-811 Trial Met Dual Primary Endpoint of Overall Survival (OS) as First-Line Treatment in Patients With HER2-Positive Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma	NYSE:MRK	Merck and Co Inc
2024/04/29	22 : 00	Business Wire	Merck Announces Positive Data for V116, an Investigational, 21-Valent Pneumococcal Conjugate Vaccine Specifically Designed for Adults	NYSE:MRK	Merck and Co Inc
2024/04/26	05 : 40	IH Market News	U.S. Stocks Climb Well Off Worst Levels But Close Mostly Lower	NYSE:MRK	Merck and Co Inc
2024/04/25	22 : 09	IH Market News	Futures Pointing To Sharply Lower Open On Wall Street	NYSE:MRK	Merck and Co Inc
2024/04/25	20 : 52	IH Market News	Southwest Shares Tumble 9.6% Post $231 Million 1Q Loss, AstraZeneca Surges on 19% Annual Increase, and More on Earnings	NYSE:MRK	Merck and Co Inc
2024/04/25	19 : 30	Business Wire	Merck Announces First-Quarter 2024 Financial Results	NYSE:MRK	Merck and Co Inc
2024/04/19	20 : 04	PR Newswire (Canada)	Santé Canada approuve KEYTRUDA® comme traitement de première intention, en association avec une chimiothérapie à base de fluoropyrimidine et de platine, des adultes atteints d'un adénocarcinome gastrique ou de la jonction gastro-œsophagienne (JGO) H	NYSE:MRK	Merck and Co Inc
2024/04/19	20 : 04	PR Newswire (Canada)	Health Canada Approves KEYTRUDA® as a first-line treatment for adult patients with locally advanced unresectable or metastatic HER2-negative gastric or gastroesophageal junction (GEJ) adenocarcinoma in combination with fluoropyrimidine- and platinum-conta	NYSE:MRK	Merck and Co Inc
2024/04/10	20 : 13	IH Market News	Delta Generates US$37 Million Profit in Q1, Google and Intel Unveil Cutting-Edge AI Chips, and More News	NYSE:MRK	Merck and Co Inc
2024/04/04	19 : 45	Business Wire	Merck Initiates Phase 3 Clinical Trial of MK-1084, an Investigational Oral KRAS G12C Inhibitor, in Combination with KEYTRUDA® (pembrolizumab) for First-Line Treatment of Certain Patients With Metastatic Non-Small Cell Lung Cancer	NYSE:MRK	Merck and Co Inc
2024/04/03	21 : 00	Business Wire	REJOICE-Ovarian01 Phase 2/3 Trial of Raludotatug Deruxtecan Initiated in Patients with Platinum-Resistant Ovarian Cancer	NYSE:MRK	Merck and Co Inc
2024/04/01	19 : 45	Business Wire	Merck to Hold First-Quarter 2024 Sales and Earnings Conference Call April 25	NYSE:MRK	Merck and Co Inc
2024/03/28	19 : 45	Business Wire	European Commission Approves Merck’s KEYTRUDA® (pembrolizumab) Plus Chemotherapy as Neoadjuvant Treatment, Then Continued as Monotherapy as Adjuvant Treatment, for Resectable Non-Small Cell Lung Cancer (NSCLC) at High Risk of Recurrence in Adults	NYSE:MRK	Merck and Co Inc
2024/03/27	19 : 54	IH Market News	GameStop Shares Tumble 20% in Pre-Market Trading Amid Revenue Decline, Direct Digital Plummets 42%, and More News	NYSE:MRK	Merck and Co Inc
2024/03/27	07 : 21	Business Wire	FDA Approves Merck’s WINREVAIR™ (sotatercept-csrk), a First-in-Class Treatment for Adults with Pulmonary Arterial Hypertension (PAH, WHO* Group 1)	NYSE:MRK	Merck and Co Inc
2024/03/21	19 : 45	Business Wire	Merck Provides Update on Phase 3 KEYLYNK-006 Trial Evaluating KEYTRUDA® (pembrolizumab) Plus Maintenance LYNPARZA® (olaparib) for Certain Patients With Metastatic Nonsquamous Non-Small Cell Lung Cancer	NYSE:MRK	Merck and Co Inc
2024/03/19	22 : 00	Business Wire	Merck Announces Positive Data on V116, an Investigational, 21-Valent Pneumococcal Conjugate Vaccine Specifically Designed for Adults, Demonstrated Immune Responses in Adults	NYSE:MRK	Merck and Co Inc
2024/03/16	05 : 23	PR Newswire (US)	FarmSee Ltd Announces the Completion of a Minority Investment in its Swine Monitoring Platform	NYSE:MRK	Merck and Co Inc
2024/03/15	19 : 45	Business Wire	Merck’s KEYTRUDA® (pembrolizumab) Plus Chemoradiotherapy (CRT) Significantly Improved Overall Survival (OS) Versus CRT Alone in Patients With Newly Diagnosed High-Risk Locally Advanced Cervical Cancer	NYSE:MRK	Merck and Co Inc
2024/03/13	16 : 00	Business Wire	Merck Announces Plans to Conduct Clinical Trials of a Novel Investigational Multi-Valent Human Papillomavirus (HPV) Vaccine and Single-Dose Regimen for GARDASIL®9	NYSE:MRK	Merck and Co Inc
2024/03/11	21 : 15	Business Wire	Merck Completes Acquisition of Harpoon Therapeutics, Inc.	NYSE:MRK	Merck and Co Inc
2024/03/07	00 : 25	Business Wire	Gilead and Merck Announce Phase 2 Data Showing an Investigational Oral Once-Weekly Combination Regimen of Islatravir and Lenacapavir Maintained Viral Suppression at Week 24	NYSE:MRK	Merck and Co Inc
2024/03/05	23 : 03	IH Market News	Futures Pointing To Continued Weakness On Wall Street	NYSE:MRK	Merck and Co Inc
2024/03/05	20 : 45	Business Wire	Merck to Participate in the Barclays 26th Annual Global Healthcare Conference	NYSE:MRK	Merck and Co Inc

Showing the most relevant articles for your search:NYSE:MRK

1 2 3 4 5 6 7 8 9 10 次へ >>

Verizon Communications

JP Morgan Chase

US Dollar vs Euro

Health Care Select Sector

Energy Select Sector SPDR

Financial Select Sector

Gold vs US Dollar

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約